Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
The article discusses the modern principles of lipid-lowering therapy and approaches to its administration in terms of levels of cardiovascular risk. The characteristics of groups of patients with different levels of cardiovascular risk (from low to high) in primary prevention are given. The article...
Enregistré dans:
Auteurs principaux: | Marina G. Bubnova, Marianna Y. Ilchenko, Petr A. Lebedev |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Concilium Medicum
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5f5a0142ea2a45fc9cae20eea8f53e85 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Statins and diabetes: focus on pitavastatin
par: Soreiia A. Urazgildeeva
Publié: (2020) -
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
par: Sydney B Long, et autres
Publié: (2010) -
Impact of adherence, patient perception, and knowledge to statin therapy – A cross-sectional study
par: Siddhi Umarje, et autres
Publié: (2021) -
Normative data on cardiovascular autonomic function in Greenlandic Inuit
par: Jesper Fleischer, et autres
Publié: (2021) -
Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
par: Peter Rossing, et autres
Publié: (2021)